文献速递肝病

肝硬化患者肌肉痉挛的管理:随机对照试验的系统综述

Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials.
PubMed 文献 · Aliment Pharmacol Ther · 2024-11-15

本系统综述检索了PubMed、MEDLINE(Ovid)、Embase和Scopus数据库,纳入12项随机对照试验、评估13种干预措施。结果显示巴氯芬、美索巴莫、奥芬那君和牛磺酸补充剂可降低痉挛频率、严重程度和持续时间;人血白蛋白、普瑞巴林和奎尼丁可降低频率;酸黄瓜汁可降低严重程度;电针是唯一无治疗效果的干预;普瑞巴林是唯一与显著副作用相关并限制其使用的药物。作者认为需要高质量随机对照试验进一步研究这些治疗的比较疗效和安全性。

要点

  • 美索巴莫、奥芬那君和牛磺酸补充剂在安慰剂对照随机对照试验中可降低肝硬化患者痉挛频率、严重程度和持续时间。
  • 巴氯芬、人血白蛋白、普瑞巴林、奎尼丁、酸黄瓜汁等干预也显示对痉挛有正面影响,电针是唯一无治疗效果的干预。
  • 普瑞巴林是唯一与显著副作用相关并限制其使用的药物。

核心结论

  • 美索巴莫、奥芬那君和牛磺酸补充剂在安慰剂对照随机对照试验中被发现可有效降低肝硬化患者的痉挛频率、严重程度和持续时间。
  • 除电针外,文中报告的所有其他干预措施均对痉挛显示出正面影响。
  • 需要高质量随机对照试验进一步研究这些治疗在比较疗效和安全性方面的应用。

研究设计与样本

  • 系统综述,检索PubMed、MEDLINE(Ovid)、Embase和Scopus数据库,检索日期为6月30日,由两名独立评审员识别报告肝硬化患者肌肉痉挛干预措施的随机对照试验。
  • 共纳入12项随机对照试验,评估13种不同的干预措施。

主要发现

  • 巴氯芬、美索巴莫、奥芬那君和牛磺酸补充剂与安慰剂相比降低痉挛频率、严重程度和持续时间。
  • 人血白蛋白、普瑞巴林和奎尼丁与安慰剂相比降低痉挛频率。
  • 酸黄瓜汁与安慰剂相比降低痉挛严重程度。
  • BCAA补充剂和碳酸钙与基线相比降低痉挛频率。
  • 拉伸显示降低痉挛严重程度和频率的信号,冥想仅在与他基线相比时显示降低严重程度的信号;电针是唯一无治疗效果的干预;普瑞巴林是唯一与显著副作用相关并限制其使用的药物。

局限性

  • 需要高质量随机对照试验进一步研究这些治疗在比较疗效和安全性方面的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Muscle cramps are common in patients with cirrhosis. Despite their prevalence and impact on health-related quality of life, there are no widely used clinical practice guidelines for management of muscle cramps in cirrhosis. The aim of this review was to critically evaluate current evidence regarding treatment of muscle cramps in cirrhosis. METHODS: A systematic review using PubMed, MEDLINE (Ovid), Embase, and Scopus databases was performed on 30 June by two independent reviewers to identify randomised controlled trials (RCTs) reporting interventions for muscle cramps in cirrhotic patients. RESULTS: Twelve RCTs evaluating 13 distinct interventions were identified. Baclofen, methocarbamol, orphenadrine, and taurine supplementation reduced cramp frequency, severity, and duration when compared to placebo. Human albumin, pregabalin, and quinidine reduced cramp frequency compared to placebo. Pickle juice reduced cramp severity compared to placebo. BCAA supplementation and calcium carbonate were found to reduce cramp frequency compared to baseline. Stretching demonstrated a signal towards reducing cramp severity and frequency, and meditation had a signal towards reducing severity only when compared to baseline. Electro-acupuncture was the only intervention which demonstrated no therapeutic effect. Pregabalin was the only agent associated with significant side effects that limited its use. CONCLUSION: Methocarbamol, orphenadrine, and taurine supplementation were found in placebo-controlled RCTs to be effective in reducing cramp frequency, severity, and duration in cirrhotic patients. All other interventions reported aside from electro-acupuncture demonstrated a positive impact on cramps. High-quality RCTs are needed to further investigate the use of these treatments in terms of comparative efficacy and safety.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Roberts AT, Makar J, Abdelmalak J, et al. Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials. Aliment Pharmacol Ther. 2024. PMID: 39548657. doi:10.1111/apt.18398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。